About Danielle Fry
Danielle Fry is a chief operating officer and chief legal officer at Ensho Therapeutics.
Danielle Fry first appears on SEC filings in 2024.
Experience
This experience comes from Danielle Fry's profile and from SEC filings. For roles taken from filings, the years are when the filings name Danielle Fry in the role, so the role may have started earlier or lasted longer.
Ensho Therapeutics, Inc. Current
Chief Operating Officer and Chief Legal Officer
Chief Legal Officer & Chief Operating Officer (2024 – Present)
2024 – Present · Woodcliff Lake, NJ
Develops oral medicines for people with inflammatory diseases.
EU
Eisai US
Assistant General Counsel
2013 – 2024
RL
Reed Smith LLP
Associate
2009 – 2013
SP
Schering Plough
Assistant Scientist
2005 – 2006
Key Colleagues at Startups
The people Danielle Fry works with at each company, as listed on that company's latest Form D.
Ensho Therapeutics, Inc. · Form D, Oct 15, 2026
AR
Arash Rassoulpour
Director
CS
Carlos Solorzano
Director
EP
Eric Pham
Director
Gerhard Hagn
Chief Executive Officer and director
NG
Neena Bitritto-Garg
Founder and Chief Executive Officer, director
TK
Tariq Kassum
Director